"Anger and Invective," and Scholarly Communication
How different issues bear on facts vs. feelings has a lot to do with how vitriolic exchanges can get.
How different issues bear on facts vs. feelings has a lot to do with how vitriolic exchanges can get.
Fewer than half of NIH sponsored clinical trials are published within 30 months, and 4 out of 5 FDA trials fail to publicly register results (as mandated by law), studies published in the BMJ report. Authors and sponsors may be the strongest source of reporting bias.
Why is there such invective around certain topics in scholarly publishing? Perhaps when you ask questions and play with ideas, you’re bound to get some backlash. But how far is too far?
Can we learn a lesson from a prior clash of RWA and FRPAA years ago?
Editors of business journals strategically coerce authors to increase citation rates, a new study in Science reports.
The Elsevier boycott puts a target on one company, but for no clear reason when you look harder at the facts, and the demands aren’t clear. Just what kind of boycott is this?
The boycott of Elsevier may have unintended consequences for smaller not-for-profits, scientists in smaller domains, and accessibility overall. And examples of solutions don’t look like solutions once you understand them a bit better.
When it comes to discussions about access, the silent majority focused on doing science is presented with real choices, not all of which square with the scorched-earth rhetoric that too often dominates.
A major economics association establishes conflict of interest and disclosure rules for its publications, expecting others to follow. But is the lateness of these rules reassuring, or maddening?
The secret to a beautiful you? Just apply this, and all your concerns about your appearance can disappear.
Follow the money in academic publishing, and you find ponds that resemble the larger lakes of academia in general. By mimicking endowment practices originating at large universities, are not-for-profits limiting their ability to grow?
Can tweets predict future citations? A study of article tweets raises validity and ethical concerns.
Amazon’s retail juggernaut has many people upset, but perhaps we should all reflect on the fact that a company devoted to customer service, thin margins, and a long-term disciplined strategy can thrive.
A controversial request that two journals censor full data reporting for fear of bioterror raises many questions, points to precedents, and hints at a better way to handle the problem than stifling scientific information.
As we continue to measure the number of papers, citations, and the combination, perhaps we should be measuring a much lower number — the number of studies that can be replicated after publication.